TARGET

Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024

Retrieved on: 
Venerdì, Maggio 3, 2024
Infection, Kidney, FDA, Administration, Staphylococcus, ASPR, HHS, SAB, Safety, Ceftobiprole, Methicillin-resistant Staphylococcus aureus, Food, Ceftriaxone, ESCMID, Daptomycin, Partnership, Fungal infection, Development, CABP, TARGET, ABSSSI, Patient, Staphylococcus aureus, Dialysis, Bronchopneumonia, MRSA, Vaccine

Data presented on a third poster demonstrated that bloodstream clearance was achieved at a median of four days after the start of treatment in both the ceftobiprole and comparator groups.

Key Points: 
  • Data presented on a third poster demonstrated that bloodstream clearance was achieved at a median of four days after the start of treatment in both the ceftobiprole and comparator groups.
  • In the group treated with ceftobiprole, fewer patients had Staphylococcus aureus-positive blood cultures after ten days compared to the comparator treatment group.
  • An oral presentation focused on a re-analysis of the previously conducted ceftobiprole phase 3 study in patients with community-acquired bacterial pneumonia (CABP).
  • Using the FDA-CABP-2020 primary endpoint of early clinical success at day 3 after study start, this re-analysis supported the non-inferiority of ceftobiprole to ceftriaxone ± linezolid.

Tokyo Metropolitan Government announces SusHi Tech Tokyo Global Startup Program 2024

Retrieved on: 
Mercoledì, Maggio 1, 2024
Koto, TMG, Suntory, Tokyo International Forum, City, Innovation, University, Future, Culture, TARGET, Google.org, Ageing, Student, Mistletoe, SAN, Harvard Business Review, Video game

SAN FRANCISCO, May 1, 2024 /PRNewswire/ -- The Tokyo Metropolitan Government (TMG) announced that the "SusHi Tech Tokyo 2024 Global Startup Program", Asia's largest global innovation conference, will be held on May 15-16, 2024. The event will be returning to great success, with expected participation almost doubling at over 40,000 visitors across 2 days, with more than 400 local and international exhibitors from 40 cities.

Key Points: 
  • SAN FRANCISCO, May 1, 2024 /PRNewswire/ -- The Tokyo Metropolitan Government (TMG) announced that the "SusHi Tech Tokyo 2024 Global Startup Program" , Asia's largest global innovation conference, will be held on May 15-16, 2024.
  • SusHi Tech Tokyo stands for Sustainable High City Tokyo.
  • SusHi Tech Tokyo Global Startup Program 2024 Executive Committee said, "SusHi Tech Tokyo 2024 Global Startup Program is Asia's largest global innovation conference, and I am honored to welcome such a prestigious and meaningful event right here in Tokyo.
  • This year, TMG levels up further with SusHi Tech Tokyo 2024 as Asia's largest global startup event including contents such as speaking sessions, a pitch contest and exhibits.

Feedback on the input provided by the European Parliament as part of its resolution on the ECB’s Annual Report 2022

Retrieved on: 
Giovedì, Aprile 18, 2024
Crypto, European banking union, Governance, Exercise, TARGET, Ciccarelli, Single, Climate, OJ, Ethics, Carbon, ECRB, Parliament, Council, European Systemic Risk Board, European Commission, Paris Agreement, Television, Annual, Letter, Speech, Employment, Social, ESRB, Euro, Prejudice, FSB, AML, ECB, Blog, Risk, ESCB, Committee, NGFS, Policy, Woman, Suggestion, Radio, GDP, Privacy, Weather, Person, Climate change, Communication, Digital, Intelligence, Economic and monetary union, SSM, Bias, Knowledge, Mentorship, EMU, Commission, Economy, Publication, Annual report, Financial Action Task Force, Orientation, Nickel, NPL, European Central Bank, Uncertainty, Financial Stability Board, Conference, NCBS, Treaty, Growth, Financial system, Central bank, European Parliament, Network, Natural Resources, COVID-19, Terrorism, Bank, Female, IMF, Multi-function printer, Recreation, Memorandum, Data, AMLA, Security printing

Beyond managing related risks, the financial sector can also contribute to the transition toward a net-zero economy.

Key Points: 
  • Beyond managing related risks, the financial sector can also contribute to the transition toward a net-zero economy.
  • Our work aims to enhance data transparency in climate change analysis, while informing monetary policy, financial stability and banking supervision.
  • The indicators we have developed focus on the euro area financial sector and are built from harmonised granular datasets.

Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications

Retrieved on: 
Giovedì, Aprile 4, 2024
Disease, MSSA, MRSA, Development, TARGET, Associate, Partnership, CABP, New Drug Application, Patient, HHS, Mortality, NDA, Fungal infection, Staphylococcus aureus, Bronchopneumonia, Infection, Safety, SAB, ASPR, Staphylococcus, Ceftobiprole, Administration, FDA, ABSSSI, Pharmaceutical industry

David Veitch, Chief Executive Officer of Basilea, said: “We are excited with the US approval of ZEVTERA.

Key Points: 
  • David Veitch, Chief Executive Officer of Basilea, said: “We are excited with the US approval of ZEVTERA.
  • The positive decision by the FDA is a key milestone towards bringing ZEVTERA to patients in the US.
  • This approval is a landmark for ceftobiprole and reflects its broad clinical utility.
  • Through this partnership, Basilea has been awarded approximately USD 112 million, or approximately 75 percent of the costs related to the SAB and ABSSSI phase 3 studies, regulatory activities and non-clinical work.

Denmark joins T2 and TIPS to fully integrate Danish krone in Eurosystem’s payment services

Retrieved on: 
Mercoledì, Aprile 3, 2024
Reproduction, European Central Bank, TARGET, TIPS, ECB, Danmarks Nationalbank, Frankfurt, Communication, T2S, Eurosystem

- PRESS RELEASE

Key Points: 
  • - PRESS RELEASE
    Denmark joins T2 and TIPS to fully integrate Danish krone in Eurosystem’s payment services
    21 March 2024
    - ECB and Danmarks Nationalbank sign agreement for Denmark to join T2 and TIPS in April 2025
    - Danish krone to become third currency available for instant payment settlement in TIPS
    The European Central Bank (ECB) and Danmarks Nationalbank today signed an agreement for Denmark to join the ECB’s T2 wholesale payment system and the TARGET Instant Payment Settlement (TIPS) service.
  • Danish financial market participants have started testing both systems in preparation for the launch in April 2025.
  • The inclusion of the Danish krone in the Eurosystem’s payment services will enable market participants in Denmark to use all three TARGET services to settle all payments and securities in their national currency and to benefit from optimised liquidity management.
  • The multicurrency capabilities of TARGET Services were first activated for the T2S platform when Danmarks Nationalbank joined with the Danish krone in October 2018.

The Eurosystem policy response to developments in retail payments

Retrieved on: 
Mercoledì, Febbraio 7, 2024
Crypto, Multilateralism, Civil service commission, Section 2, International, Fraud, Ecosystem, Privacy, SIPS, Aggression, Architecture, Bank, ECB, OJ, Digital divide, Finance, Section 3, Internet, SPACE, Knowledge, Principle, Bank for International Settlements, Safety, FSB, PFMI, Council, Blog, TARGET, Artificial intelligence, CPSS, Central bank, Committee, ECRB, CPMI, IOSCO, Payment, International Organization (journal), Acceleration, Single Euro Payments Area, European Commission, Speech, Coronavirus, European Central Bank, Risk, Financial market, Face, Motivation, Euro, ICT, Policy, IBAN, Payments Council, European, Digital, Section 4, Fintech, European Payments Initiative, Digitalization, Perception, News, Instant, Sale, European Parliament, Conference, Online shopping

Retail payments are undergoing profound changes that are reshaping the European payments landscape.

Key Points: 
  • Retail payments are undergoing profound changes that are reshaping the European payments landscape.
  • The retail payments ecosystem and consumers’ attitudes and preferences are evolving and influencing one another.

Ring Energy Announces Issuance of 2023 Sustainability Report

Retrieved on: 
Giovedì, Dicembre 28, 2023
Greenhouse gas, Culture, ...Continued, Sustainable Development Goals, Acquisition, GHG, Health, ESG, REI, Disclosure, United, Social, Task force, Feedback, CBP, TARGET, Safety, United Nations, Renewable energy

THE WOODLANDS, Texas, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that it has issued its 2023 Sustainability Report (the “2023 Report”), which is available on the Company’s website at www.ringenergy.com under the “Sustainability” tab.

Key Points: 
  • THE WOODLANDS, Texas, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today announced that it has issued its 2023 Sustainability Report (the “2023 Report”), which is available on the Company’s website at www.ringenergy.com under the “Sustainability” tab.
  • The report provides updated and comprehensive information about Ring’s Environmental, Social and Governance (“ESG”) initiatives and related key performance indicators.
  • During 2022 and into 2023, the Company has executed a number of its targeted ESG initiatives, and these projects are discussed in the 2023 Report.
  • We are confident our 2023 Report showcases our progress on these important fronts.”

Ulta-Lit wins 3-year IP battle but now faces new problem with the same AZ firm

Retrieved on: 
Giovedì, Dicembre 7, 2023
Ulta, Learning, Light-emitting diode, LED, Holiday, Patent, Frustration, Guilt, Lighthouse, SLS, EACH, Christmas, TARGET, United States patent law

GLENVIEW, Ill., Dec. 07, 2023 (GLOBE NEWSWIRE) -- Ulta-Lit Tree Company, the leading provider of Christmas light repair products, is battling Simple Living Solutions, LLC (SLS), a company that has infringed Ulta-Lit’s US Patent # 9,500,719. Following Ulta-Lit’s assertion against SLS of this patent in a lawsuit, which was resolved favorably last summer, SLS ceased distribution of the infringing product after an admission of guilt. They will be paying Ulta-Lit monies for 3 more years per contract.

Key Points: 
  • It is used to identify and repair broken incandescent light sets without the need to replace entire strands.
  • “Our Quick Fix for incandescent and insulation piercing for LED are the long-accepted industry standards for rapid and effective repair.
  • That’s like inserting a screwdriver into a live circuit, to what end?”, said John DeCosmo, founder and owner of Ulta-Lit.
  • Ulta-Lit has taken over 10,000 phone calls and emails in 25+ years, striving to keep the consumers’ holidays bright.

A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests

Retrieved on: 
Mercoledì, Dicembre 6, 2023
DOI, Nature, Marc, Allergy, Cancer research, Patient, Lung cancer, National Institutes of Health, TARGET, Cancer, Doctor of Philosophy, Bangladesh Technical Education Board, Cancer Research Institute, Bristol Myers Squibb, Dermatitis, Immunology, Biomarker, Columbia University, Bone marrow, Immunity, Artificial intelligence, MTR, Austrian Academy of Sciences, CRI, Asthma, AACR, FAAD, Hope, Clinical trial, Mouse, Agency, Immunotherapy, Treatment of lung cancer, Human, SingHealth, Neoplasm, NSCLC, Vaccine, Pharmaceutical industry, Science, Chin, Research, MD

NEW YORK, Dec. 6, 2023 /PRNewswire-PRWeb/ -- Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).

Key Points: 
  • Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).
  • NEW YORK, Dec. 6, 2023 /PRNewswire-PRWeb/ -- Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC).
  • "Strikingly, we found that IL-4 blockade enhanced lung cancer response to checkpoint blockade in mice and in six lung cancer patients with treatment-resistant disease.
  • "In our relentless pursuit of progress, the Cancer Research Institute (CRI) proudly supports the visionary team at the Icahn School of Medicine at Mount Sinai.

Target RWE Releases Important Updates on the Cirrhosis Quality Collaborative/TARGET-Liver Disease Partnership with the American Association for the Study of Liver Diseases

Retrieved on: 
Venerdì, Novembre 10, 2023
MSHS, Calibration, Disease, Hepatology, Safety, Prevalence, Entrepreneurship, AASLD, CQC, Liver disease, Mortality, Chief Medical Officer (Ireland), Fatty liver disease, Patient, Liver, Cirrhosis, TARGET, Chronic liver disease, Partnership, Quality of life, LD, American Heart, RWE, American Heart Association, Pharmaceutical industry, Boston

DURHAM, N.C., Nov. 10, 2023 /PRNewswire/ -- Real-world evidence (RWE) leader Target RWE announced today that the CQC and TARGET-Liver Disease (LD) partnership with the American Association for the Study of Liver Diseases (AASLD) has enrolled approximately 75,000 patients.

Key Points: 
  • DURHAM, N.C., Nov. 10, 2023 /PRNewswire/ -- Real-world evidence (RWE) leader Target RWE announced today that the CQC and TARGET-Liver Disease (LD) partnership with the American Association for the Study of Liver Diseases (AASLD) has enrolled approximately 75,000 patients.
  • Target RWE has enrolled approximately 75,000+ patients under the TARGET-LD protocol to support AASLD/CQC.
  • The strategic partnership between Target RWE and AASLD is designed to fulfill the unmet need for a large, real-world registry of patients with chronic liver diseases.
  • "These liver diseases are growing in prevalence and are placing a tremendous burden on healthcare systems around the world.